Global Remifentanil Hydrochloride for Injection Market Growth 2024-2030

Publication ID:

LPI08246166

Publication Date:

August 21, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Remifentanil Hydrochloride for Injection has analgesic effect. The main active ingredient is remifentanil, which belongs to opioid agonists. It exerts obvious analgesic effect by stimulating opioid receptors.
The global Remifentanil Hydrochloride for Injection market size is projected to grow from US$ 405 million in 2023 to US$ 751.5 million in 2030; it is expected to grow at a CAGR of 9.2% from 2024 to 2030.
The 鈥淩emifentanil Hydrochloride for Injection Industry Forecast鈥� looks at past sales and reviews total world Remifentanil Hydrochloride for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Remifentanil Hydrochloride for Injection sales for 2024 through 2030. With Remifentanil Hydrochloride for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Remifentanil Hydrochloride for Injection industry.
This Insight Report provides a comprehensive analysis of the global Remifentanil Hydrochloride for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Remifentanil Hydrochloride for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Remifentanil Hydrochloride for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Remifentanil Hydrochloride for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Remifentanil Hydrochloride for Injection.
United States market for Remifentanil Hydrochloride for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Remifentanil Hydrochloride for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Remifentanil Hydrochloride for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Remifentanil Hydrochloride for Injection players cover Jiangsu Nhua Pharmaceutical, Yichang Renfu Pharmaceutical, Sinopharm Group, Aspen and Fresenius Kab and etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Remifentanil Hydrochloride for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
1mg/vial
2mg/vial
5mg/via
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Jiangsu Nhua Pharmaceutical
Yichang Renfu Pharmaceutical
Sinopharm Group
Aspen
Fresenius Kab
Sandoz
Key Questions Addressed in this Report
What is the 10-year outlook for the global Remifentanil Hydrochloride for Injection market?
What factors are driving Remifentanil Hydrochloride for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Remifentanil Hydrochloride for Injection market opportunities vary by end market size?
How does Remifentanil Hydrochloride for Injection break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Remifentanil Hydrochloride for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Remifentanil Hydrochloride for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Remifentanil Hydrochloride for Injection by Country/Region, 2019, 2023 & 2030
2.2 Remifentanil Hydrochloride for Injection Segment by Type
2.2.1 1mg/vial
2.2.2 2mg/vial
2.2.3 5mg/via
2.3 Remifentanil Hydrochloride for Injection Sales by Type
2.3.1 Global Remifentanil Hydrochloride for Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Remifentanil Hydrochloride for Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Remifentanil Hydrochloride for Injection Sale Price by Type (2019-2024)
2.4 Remifentanil Hydrochloride for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Remifentanil Hydrochloride for Injection Sales by Application
2.5.1 Global Remifentanil Hydrochloride for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Remifentanil Hydrochloride for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Remifentanil Hydrochloride for Injection Sale Price by Application (2019-2024)
3 Global Remifentanil Hydrochloride for Injection by Company
3.1 Global Remifentanil Hydrochloride for Injection Breakdown Data by Company
3.1.1 Global Remifentanil Hydrochloride for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Remifentanil Hydrochloride for Injection Sales Market Share by Company (2019-2024)
3.2 Global Remifentanil Hydrochloride for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Remifentanil Hydrochloride for Injection Revenue by Company (2019-2024)
3.2.2 Global Remifentanil Hydrochloride for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Remifentanil Hydrochloride for Injection Sale Price by Company
3.4 Key Manufacturers Remifentanil Hydrochloride for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Remifentanil Hydrochloride for Injection Product Location Distribution
3.4.2 Players Remifentanil Hydrochloride for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Remifentanil Hydrochloride for Injection by Geographic Region
4.1 World Historic Remifentanil Hydrochloride for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Remifentanil Hydrochloride for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Remifentanil Hydrochloride for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Remifentanil Hydrochloride for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Remifentanil Hydrochloride for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Remifentanil Hydrochloride for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Remifentanil Hydrochloride for Injection Sales Growth
4.4 APAC Remifentanil Hydrochloride for Injection Sales Growth
4.5 Europe Remifentanil Hydrochloride for Injection Sales Growth
4.6 Middle East & Africa Remifentanil Hydrochloride for Injection Sales Growth
5 Americas
5.1 Americas Remifentanil Hydrochloride for Injection Sales by Country
5.1.1 Americas Remifentanil Hydrochloride for Injection Sales by Country (2019-2024)
5.1.2 Americas Remifentanil Hydrochloride for Injection Revenue by Country (2019-2024)
5.2 Americas Remifentanil Hydrochloride for Injection Sales by Type
5.3 Americas Remifentanil Hydrochloride for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Remifentanil Hydrochloride for Injection Sales by Region
6.1.1 APAC Remifentanil Hydrochloride for Injection Sales by Region (2019-2024)
6.1.2 APAC Remifentanil Hydrochloride for Injection Revenue by Region (2019-2024)
6.2 APAC Remifentanil Hydrochloride for Injection Sales by Type
6.3 APAC Remifentanil Hydrochloride for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Remifentanil Hydrochloride for Injection by Country
7.1.1 Europe Remifentanil Hydrochloride for Injection Sales by Country (2019-2024)
7.1.2 Europe Remifentanil Hydrochloride for Injection Revenue by Country (2019-2024)
7.2 Europe Remifentanil Hydrochloride for Injection Sales by Type
7.3 Europe Remifentanil Hydrochloride for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Remifentanil Hydrochloride for Injection by Country
8.1.1 Middle East & Africa Remifentanil Hydrochloride for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Remifentanil Hydrochloride for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Remifentanil Hydrochloride for Injection Sales by Type
8.3 Middle East & Africa Remifentanil Hydrochloride for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Remifentanil Hydrochloride for Injection
10.3 Manufacturing Process Analysis of Remifentanil Hydrochloride for Injection
10.4 Industry Chain Structure of Remifentanil Hydrochloride for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Remifentanil Hydrochloride for Injection Distributors
11.3 Remifentanil Hydrochloride for Injection Customer
12 World Forecast Review for Remifentanil Hydrochloride for Injection by Geographic Region
12.1 Global Remifentanil Hydrochloride for Injection Market Size Forecast by Region
12.1.1 Global Remifentanil Hydrochloride for Injection Forecast by Region (2025-2030)
12.1.2 Global Remifentanil Hydrochloride for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Remifentanil Hydrochloride for Injection Forecast by Type
12.7 Global Remifentanil Hydrochloride for Injection Forecast by Application
13 Key Players Analysis
13.1 Jiangsu Nhua Pharmaceutical
13.1.1 Jiangsu Nhua Pharmaceutical Company Information
13.1.2 Jiangsu Nhua Pharmaceutical Remifentanil Hydrochloride for Injection Product Portfolios and Specifications
13.1.3 Jiangsu Nhua Pharmaceutical Remifentanil Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Jiangsu Nhua Pharmaceutical Main Business Overview
13.1.5 Jiangsu Nhua Pharmaceutical Latest Developments
13.2 Yichang Renfu Pharmaceutical
13.2.1 Yichang Renfu Pharmaceutical Company Information
13.2.2 Yichang Renfu Pharmaceutical Remifentanil Hydrochloride for Injection Product Portfolios and Specifications
13.2.3 Yichang Renfu Pharmaceutical Remifentanil Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Yichang Renfu Pharmaceutical Main Business Overview
13.2.5 Yichang Renfu Pharmaceutical Latest Developments
13.3 Sinopharm Group
13.3.1 Sinopharm Group Company Information
13.3.2 Sinopharm Group Remifentanil Hydrochloride for Injection Product Portfolios and Specifications
13.3.3 Sinopharm Group Remifentanil Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sinopharm Group Main Business Overview
13.3.5 Sinopharm Group Latest Developments
13.4 Aspen
13.4.1 Aspen Company Information
13.4.2 Aspen Remifentanil Hydrochloride for Injection Product Portfolios and Specifications
13.4.3 Aspen Remifentanil Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Aspen Main Business Overview
13.4.5 Aspen Latest Developments
13.5 Fresenius Kab
13.5.1 Fresenius Kab Company Information
13.5.2 Fresenius Kab Remifentanil Hydrochloride for Injection Product Portfolios and Specifications
13.5.3 Fresenius Kab Remifentanil Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Fresenius Kab Main Business Overview
13.5.5 Fresenius Kab Latest Developments
13.6 Sandoz
13.6.1 Sandoz Company Information
13.6.2 Sandoz Remifentanil Hydrochloride for Injection Product Portfolios and Specifications
13.6.3 Sandoz Remifentanil Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sandoz Main Business Overview
13.6.5 Sandoz Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂